IONS Ionis Pharmaceuticals, Inc. - Common Stock
$58,28
Prezzo · Ago 18, 2026
Fondamentali al Lug 29, 2026
Intervallo 52 sett.
$42–$87
37% of range
Rating Analisti
BUY
31 analysts
Prezzo Obiettivo
$89
+53% upside
P/E (TTM)
-24.5
ROE
-68.1%
Margine di Profitto Netto
—
IONS Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$58.28
Capitalizzazione di Mercato
$9.52B
P/E (TTM)
-24.5
EPS (TTM)
$-2.38
Ricavi (TTM)
—
Rendimento div.
—
ROE
-68.1%
D/E Debito/Patrimonio
3.6
Intervallo 52 sett.
$42 – $87
IONS Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
—
2016-12-31
→
2017-12-31
EPS
$-2.38
2016-12-31
→
2025-12-31
Flusso di cassa libero
$-320M
2016-12-31
→
2025-12-31
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
IONS
Mediana dei peer
P/E (TTM)
-24.5
16.0
P/S (TTM)
10.1
32.5
P/B
19.5
3.9
EV / EBITDA
-22.5
—
Price / FCF (Prezzo / FCF)
-29.7
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
IONS
Mediana dei peer
ROA
-11.7%
-22.2%
ROE
-68.1%
-37.6%
ROIC
-17.1%
—
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
IONS
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
3.6
0.0
Current Ratio (Rapporto corrente)
3.8
5.7
Quick Ratio
3.4
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
IONS
Mediana dei peer
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
IONS
Mediana dei peer
IONS Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
31 analisti
- Acquisto forte 8 25,8%
- Compra 17 54,8%
- Mantieni 6 19,4%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
21 analisti · 2026-08-18
Mediana
$90.00
← Sotto tutti i target
$58.28
Basso
$66.00
Alto
$115.00
Target mediano
$90.00
+54,4%
Target medio
$89.33
+53,3%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
0.42%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.69 | $-1.09 | 0.40% |
| 31 Marzo 2026 | $-0.56 | $-0.93 | 0.37% |
| 31 Dicembre 2025 | $-1.41 | $-1.35 | -0.06% |
| 30 Settembre 2025 | $-0.80 | $-1.26 | 0.46% |
| 30 Giugno 2025 | $0.70 | $-0.44 | 1.1% |
| 31 Marzo 2025 | $-0.93 | $-1.14 | 0.21% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| PCVX | $6.05B | -8.2 | — | — | -26.6% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
| IBRX | $2.00B | -5.2 | 668.3% | -310.2% | 71.0% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 16
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | $508M | $347M | $284M | $214M | |
| Cost of Revenue | $16M | $11M | $9M | $14M | $11M | $12M | $4M | $2M | $0 | $0 | · | · | |
| R&D Expense | $916M | $902M | $900M | · | $638M | $531M | $462M | $412M | $372M | $340M | $320M | $239M | |
| SG&A Expense | $394M | $267M | $233M | $150M | $186M | $354M | $287M | $245M | $108M | $49M | $37M | $20M | |
| Operating Expenses | $1.33B | $1.18B | $1.14B | $998M | $841M | $901M | $757M | $661M | $483M | $393M | $359M | $262M | |
| Operating Income | $-382M | $-475M | $-354M | $-410M | $-30M | $-172M | $366M | $-61M | $31M | $-20M | $-76M | $-48M | |
| Interest Expense | $17M | $17M | $13M | $8M | $9M | $10M | $12M | $45M | $45M | $39M | $37M | $22M | |
| Other Non-op | $-15M | $1M | $14M | $-7M | $-10M | $-62.0K | $-686.0K | $-182.0K | $-4M | $0 | · | · | |
| Pretax Income | $-380M | $-460M | $-334M | $-258M | $-29M | $-135M | $339M | $-76M | $-17M | $-57M | $-88M | $-54M | |
| Income Tax | $2M | $-6M | $32M | $12M | $-551.0K | $345M | $52M | $-291M | $-6M | $3M | $372.0K | $-15M | |
| Net Income | $-381M | $-454M | $-366M | $-270M | $-29M | $-444M | $278M | $274M | $346.0K | $-60M | $-88M | $-39M | |
| EPS (Basic) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.18 | $2.00 | $2.09 | $0.15 | $-0.50 | $-0.74 | · | |
| EPS (Diluted) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 | $-3.18 | $1.90 | $2.07 | $0.15 | $-0.50 | $-0.74 | · | |
| Shares (Basic) | 160,010,000 | 149,514,000 | 143,190,000 | 141,848,000 | 141,021,000 | 139,612,000 | 139,998,000 | 132,320,000 | 124,016,000 | 120,933,000 | 119,719,000 | · | |
| Shares (Diluted) | 160,010,000 | 149,514,000 | 143,190,000 | 141,848,000 | 141,021,000 | 139,612,000 | 153,164,000 | 134,056,000 | 126,098,000 | 120,933,000 | 119,719,000 | · | |
| EBITDA | $-382M | $-475M | $-354M | $-410M | $-30M | $-172M | $366M | $-61M | $25M | $-46M | $-76M | $-48M |
Stato Patrimoniale 24
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $372M | $242M | $399M | $276M | $869M | $398M | $683M | $279M | $130M | $85M | $129M | $143M | |
| Short-term Investments | $2.31B | $2.06B | $1.93B | $1.71B | $1.25B | · | · | · | · | · | · | · | |
| Inventory | $10M | $13M | $7M | $22M | $25M | $22M | $18M | $9M | $10M | · | · | · | |
| Other Current Assets | $237M | $218M | $205M | $168M | $143M | $140M | $140M | $102M | $73M | $17M | $15M | $16M | |
| Current Assets | $2.99B | $2.62B | $2.64B | $2.20B | $2.35B | $2.13B | $2.72B | $2.21B | $1.17B | $798M | $837M | $837M | |
| PP&E (Net) | $123M | $94M | $71M | $74M | $178M | $181M | $154M | $132M | $122M | $93M | $90M | $89M | |
| Accum. Depreciation | $109M | $106M | $97M | $88M | $103M | $87M | $74M | $61M | $88M | $80M | $73M | $66M | |
| Intangibles | · | · | · | · | $29M | $28M | $26M | $24M | $22M | $20M | · | · | |
| Other Non-current Assets | $172M | $127M | $105M | $75M | $71M | $50M | $28M | $13M | $10M | $1M | · | · | |
| Total Assets | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B | $3.23B | $2.67B | $1.32B | $912M | $948M | $956M | |
| Accounts Payable | $28M | $43M | $26M | $18M | $12M | $17M | $16M | $29M | $25M | $21M | $28M | $18M | |
| Accrued Liabilities | $106M | $108M | $148M | $140M | $89M | $90M | $67M | $48M | $67M | $36M | $28M | $30M | |
| Current Liabilities | $782M | $309M | $448M | $312M | $241M | $599M | $273M | $280M | $244M | $134M | $149M | $115M | |
| Capital Leases | $262M | $162M | $171M | $179M | $19M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $28M | $52M | $42M | $16M | $7M | · | · | · | · | · | · | · | |
| Total Liabilities | $3.03B | $2.42B | $2.60B | $1.96B | $1.84B | $1.65B | $1.55B | $1.48B | $957M | $813M | $747M | $698M | |
| Long-term Debt | $1.81B | $1.25B | $1.31B | $1.19B | · | · | · | · | · | · | · | · | |
| Total Debt | $1.76B | $1.20B | $1.24B | $1.18B | · | · | · | · | · | · | · | · | |
| Common Stock | $163.0K | $158.0K | $144.0K | $142.0K | $141.0K | $140.0K | $140.0K | $138.0K | $125.0K | $122.0K | $120.0K | $118.0K | |
| Retained Earnings | $-2.63B | $-2.25B | $-1.80B | $-1.43B | $-1.16B | $-1.13B | $-708M | $-967M | $-1.24B | $-1.18B | $-1.09B | $-1.01B | |
| AOCI | $-25M | $-31M | $-33M | $-57M | $-33M | $-21M | $-25M | $-32M | $-32M | $-30M | $-14M | $40M | |
| Stockholders' Equity | $489M | $588M | $387M | $573M | $772M | $743M | $1.47B | $1.05B | $281M | $100M | $201M | $258M | |
| Liabilities + Equity | $3.52B | $3.00B | $2.99B | $2.53B | $2.61B | $2.39B | $3.23B | $2.67B | $1.32B | $912M | $948M | $956M | |
| Shares Outstanding | 163,304,875 | 157,908,815 | 144,340,526 | 142,057,736 | 141,210,015 | 140,365,594 | 140,339,615 | 137,928,828 | 124,976,373 | 121,636,273 | 120,351,480 | 118,442,726 |
Flusso di cassa 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $134M | $130M | $106M | $100M | $121M | $230M | $147M | $131M | $86M | $72M | $59M | $31M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $342M | $904.0K | $-291M | $0 | $0 | $0 | $-11M | |
| Amort. of Intangibles | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Operating Cash Flow | $-269M | $-501M | $-308M | $-274M | $31M | $36M | $346M | $603M | $174M | $-112M | $21M | $6M | |
| CapEx | $51M | $45M | $24M | $16M | $12M | $35M | $31M | $14M | $35M | $7M | $8M | $8M | |
| Investing Cash Flow | $-278M | $-134M | $-214M | $-263M | $195M | $274M | $-41M | $-930M | $-358M | $57M | $-60M | · | |
| Stock Issued | $0 | $489M | $0 | $0 | · | $0 | $0 | $448M | $72M | $0 | $0 | $0 | |
| Stock Repurchased | · | · | · | $0 | $0 | $91M | $34M | $0 | $0 | · | · | · | |
| Net Stock Activity | $0 | $489M | · | $0 | $0 | $-91M | $-34M | · | $72M | · | $0 | $0 | |
| Financing Cash Flow | $676M | $478M | $644M | $-55M | $246M | $-597M | $100M | $476M | $229M | $11M | $25M | · | |
| Net Change in Cash | $130M | $-157M | $123M | $-593M | $472M | $-286M | $404M | $149M | $45M | $-44M | $-14M | · | |
| Taxes Paid | $-639.0K | $-6M | $48M | $5M | · | $26M | $9M | $0 | $0 | · | · | · | |
| Free Cash Flow | $-320M | $-546M | $-331M | $-290M | $19M | $772.0K | $315M | $589M | $139M | $-119M | $13M | $-1M | |
| Levered FCF | $-337M | $-563M | $-345M | $-299M | $10M | $-128M | $272M | $716M | $106M | $-159M | $-23M | $-17M |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | 4.8% | -13.4% | -26.7% | -22.3% | |
| Net Margin | · | · | · | · | · | · | · | · | -1.2% | -25.0% | -31.1% | -18.2% | |
| Pretax Margin | · | · | · | · | · | · | · | · | -4.6% | -24.1% | -31.0% | -25.4% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | 4.8% | -13.4% | -26.7% | -22.3% | |
| ROA | -11.7% | -15.2% | -13.3% | -10.5% | -1.1% | -16.1% | 10.0% | 13.7% | -0.53% | -9.3% | -9.2% | -4.3% | |
| ROE | -68.1% | -71.9% | -104.3% | -40.1% | -3.8% | -39.0% | 23.4% | 41.2% | -2.8% | -57.6% | -38.5% | -12.3% | |
| ROIC | -17.1% | -26.0% | -23.8% | -24.5% | -3.8% | -58.4% | 21.8% | 16.5% | 5.5% | -48.1% | -37.9% | -13.3% |
Liquidità e Solvibilità 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 8.5 | 5.9 | 7.1 | 9.7 | 3.7 | 10.0 | 7.9 | 5.2 | 6.0 | 5.6 | 7.3 | |
| Quick Ratio | 3.4 | 7.4 | 5.2 | 6.4 | 3.6 | 0.7 | 2.5 | 1.0 | 0.6 | 0.6 | 0.9 | 1.2 | |
| Debt / Equity | 3.6 | 2.0 | 3.2 | 2.1 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 2.7 | 2.0 | 3.2 | 2.1 | · | · | · | · | · | · | · | · | |
| Interest Coverage | -22.1 | -28.0 | -27.9 | -50.5 | -3.2 | -3.8 | 7.5 | -1.4 | 0.5 | -1.2 | -2.1 | -2.1 |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | 0.5 | 0.4 | 0.3 | 0.2 | |
| Inventory Turnover | 1.4 | 1.1 | 0.4 | 0.6 | 0.5 | 0.6 | 0.3 | 0.2 | · | · | · | · |
Valutazione (TTM) 14
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $944M | $705M | $788M | $587M | $810M | $729M | $1.12B | $600M | $508M | $347M | $284M | $214M | |
| Net Income TTM | $-381M | $-454M | $-366M | $-270M | $-29M | $-444M | $278M | $274M | $346.0K | $-60M | $-88M | $-39M | |
| Market Cap | $12.92B | $5.52B | $7.30B | $5.37B | $4.30B | $7.94B | $8.48B | $7.46B | $6.29B | $5.82B | $7.45B | $7.31B | |
| Enterprise Value | $12.00B | $4.43B | $6.21B | $4.55B | · | · | · | · | · | · | · | · | |
| P/E | -33.2 | -11.5 | -19.8 | -19.9 | -152.2 | -17.8 | 31.8 | 26.1 | 335.3 | -95.7 | -83.7 | -176.4 | |
| P/S | 13.7 | 7.8 | 9.3 | 9.1 | 5.3 | 10.9 | 7.6 | 12.4 | 12.4 | 16.8 | 26.3 | 34.1 | |
| P/B | 26.4 | 9.2 | 18.9 | 9.4 | 5.6 | 9.4 | 5.8 | 7.1 | 19.0 | 58.4 | 37.1 | 28.4 | |
| P / Tangible Book | 26.4 | 9.4 | 18.9 | 9.4 | 5.8 | 11.1 | · | · | · | · | · | · | |
| P / Cash Flow | -48.1 | -11.0 | -23.7 | -19.6 | 139.5 | 221.1 | 24.5 | 12.4 | 36.1 | -51.9 | 352.8 | 1163.5 | |
| P / FCF | -40.4 | -10.1 | -22.0 | -18.5 | 228.0 | 10280.1 | 26.9 | 12.7 | 45.1 | -48.8 | 554.9 | -5930.8 | |
| EV / EBITDA | -31.4 | -9.3 | -17.6 | -11.1 | · | · | · | · | · | · | · | · | |
| EV / FCF | -37.5 | -8.1 | -18.7 | -15.7 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 12.7 | 6.3 | 7.9 | 7.8 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -3.0% | -8.7% | -5.1% | -5.0% | -0.66% | -5.6% | 3.1% | 3.8% | 0.30% | -1.1% | -1.2% | -0.57% |
Conto Economico 15
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $268M | $246M | $203M | $157M | $452M | $132M | $227M | $134M | $225M | $119M | $325M | $144M | $188M | $131M | $152M | $160M | |
| Cost of Revenue | $3M | $3M | $8M | $2M | $4M | $1M | $4M | $1M | $4M | $2M | $3M | $2M | $3M | $1M | $4M | $2M | |
| SG&A Expense | $150M | $150M | $130M | $97M | $91M | $76M | $88M | $62M | $65M | $53M | $71M | $70M | $46M | $46M | $48M | $34M | |
| Operating Expenses | $370M | $364M | $418M | $317M | $312M | $278M | $337M | $282M | $291M | $269M | $331M | $287M | $279M | $245M | $360M | $219M | |
| Operating Income | $-102M | $-117M | $-214M | $-160M | $140M | $-147M | $-111M | $-149M | $-66M | $-150M | $-6M | $-143M | $-90M | $-114M | $-208M | $-59M | |
| Interest Expense | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $4M | $2M | $2M | $2M | $2M | |
| Other Non-op | $987.0K | $-456.0K | $-16M | $363.0K | $102.0K | $465.0K | $302.0K | $142.0K | $610.0K | $277.0K | $235.0K | $2M | $11M | $230.0K | $123.0K | $5M | |
| Pretax Income | $-113M | $-92M | $-228M | $-128M | $124M | $-147M | $-107M | $-144M | $-66M | $-143M | $-3M | $-141M | $-77M | $-113M | $-44M | $-47M | |
| Income Tax | $1M | $218.0K | $1M | $213.0K | $-20.0K | $116.0K | $-3M | $-4M | $64.0K | $75.0K | $6M | $7M | $8M | $11M | $8M | $283.0K | |
| Net Income | $-115M | $-93M | $-229M | $-129M | $124M | $-147M | $-104M | $-140M | $-66M | $-143M | $-9M | $-147M | $-85M | $-124M | $-52M | $-47M | |
| EPS (Basic) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.78 | $-0.93 | $-0.66 | $-0.95 | $-0.45 | $-0.98 | $-0.06 | $-1.03 | $-0.60 | $-0.87 | $-0.37 | $-0.33 | |
| EPS (Diluted) | $-0.69 | $-0.56 | $-1.41 | $-0.80 | $0.70 | $-0.93 | $-0.66 | $-0.95 | $-0.45 | $-0.98 | $-0.06 | $-1.03 | $-0.60 | $-0.87 | $-0.37 | $-0.33 | |
| Shares (Basic) | 165,419,000 | 164,874,000 | -317,627,000 | 159,765,000 | 159,137,000 | 158,735,000 | -290,575,000 | 148,593,000 | 145,958,000 | 145,538,000 | -285,960,000 | 143,317,000 | 143,098,000 | 142,735,000 | -283,495,000 | 141,950,000 | |
| Shares (Diluted) | 165,419,000 | 164,874,000 | -340,821,000 | 159,765,000 | 182,331,000 | 158,735,000 | -290,575,000 | 148,593,000 | 145,958,000 | 145,538,000 | -285,960,000 | 143,317,000 | 143,098,000 | 142,735,000 | -283,495,000 | 141,950,000 | |
| EBITDA | $-102M | $-117M | · | $-160M | $140M | $-147M | · | $-149M | $-66M | $-150M | · | $-143M | $-90M | $-114M | · | $-59M |
Stato Patrimoniale 23
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $350M | $173M | $372M | $338M | $297M | $264M | $242M | $335M | $294M | $349M | · | $352M | $425M | $309M | · | $315M | |
| Short-term Investments | $1.70B | $1.75B | $2.31B | $1.90B | $1.99B | $1.88B | $2.06B | $2.15B | $1.78B | $1.86B | · | $1.88B | $1.96B | $2.04B | · | $1.67B | |
| Inventory | $51M | $6M | $10M | $10M | $8M | $12M | $13M | $28M | $29M | $30M | · | $26M | $26M | $22M | · | $21M | |
| Other Current Assets | $327M | $306M | $237M | $244M | $226M | $223M | $218M | $184M | $195M | $174M | · | $181M | $178M | $160M | · | $143M | |
| Current Assets | $2.49B | $2.94B | $2.99B | $2.52B | $2.58B | $2.42B | $2.62B | $2.71B | $2.33B | $2.42B | · | $2.58B | $2.62B | $2.54B | · | $2.15B | |
| PP&E (Net) | $155M | $142M | $123M | $106M | $112M | $103M | $94M | $83M | $76M | $73M | · | $71M | $92M | $85M | · | $181M | |
| Accum. Depreciation | · | · | $109M | · | · | · | $106M | · | · | · | · | · | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $30M | |
| Other Non-current Assets | $117M | $136M | $172M | $166M | $132M | $132M | $127M | $120M | $119M | $106M | · | $104M | $86M | $78M | · | $59M | |
| Total Assets | $2.99B | $3.45B | $3.52B | $3.03B | $2.99B | $2.81B | $3.00B | $3.08B | $2.69B | $2.76B | · | $2.93B | $2.97B | $2.89B | · | $2.42B | |
| Accounts Payable | $48M | $26M | $28M | $14M | $23M | $17M | $43M | $9M | $9M | $13M | · | $6M | $24M | $10M | · | $21M | |
| Accrued Liabilities | $116M | $127M | $106M | $99M | $99M | $103M | $108M | $124M | $114M | $106M | · | $119M | $105M | $113M | · | $128M | |
| Current Liabilities | $316M | $717M | $782M | $903M | $897M | $250M | $309M | $305M | $306M | $328M | · | $404M | $288M | $259M | · | $283M | |
| Capital Leases | $262M | $259M | $262M | $263M | $164M | $159M | $162M | $168M | $166M | $169M | · | $173M | $175M | $177M | · | · | |
| Other Non-current Liabilities | $28M | $28M | · | $29M | $59M | $56M | · | $42M | $42M | $42M | · | $49M | $16M | $7M | · | · | |
| Total Liabilities | $2.55B | $2.96B | $3.03B | $2.42B | $2.35B | $2.34B | $2.42B | $2.42B | $2.43B | $2.47B | · | $2.62B | $2.54B | $2.40B | · | $1.83B | |
| Long-term Debt | · | · | $1.81B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $166.0K | $166.0K | $163.0K | $161.0K | $159.0K | $159.0K | $158.0K | $158.0K | $146.0K | $146.0K | · | $143.0K | $143.0K | $143.0K | · | $142.0K | |
| Retained Earnings | $-2.84B | $-2.72B | $-2.63B | $-2.40B | $-2.27B | $-2.40B | $-2.25B | $-2.15B | $-2.00B | $-1.94B | · | $-1.79B | $-1.64B | $-1.55B | · | $-1.38B | |
| AOCI | $-34M | $-31M | $-25M | $-26M | $-28M | $-29M | $-31M | $-24M | $-35M | $-35M | · | $-46M | $-51M | $-49M | · | $-63M | |
| Stockholders' Equity | $440M | $491M | $489M | $618M | $632M | $476M | $588M | $662M | $264M | $297M | $387M | $315M | $428M | $487M | $573M | $594M | |
| Liabilities + Equity | $2.99B | $3.45B | $3.52B | $3.03B | $2.99B | $2.81B | $3.00B | $3.08B | $2.69B | $2.76B | · | $2.93B | $2.97B | $2.89B | · | $2.42B | |
| Shares Outstanding | 165,636,792 | 165,902,064 | 163,304,875 | 161,137,930 | 159,196,782 | 159,041,259 | 157,908,815 | 157,813,136 | 146,025,246 | 145,844,719 | · | 143,393,493 | 143,167,414 | 143,022,539 | · | 142,017,411 |
Flusso di cassa 11
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $46M | $43M | $43M | $31M | $30M | $30M | $36M | $32M | $31M | $31M | $26M | $26M | $27M | $27M | $26M | $24M | |
| Amort. of Intangibles | $700.0K | $661.0K | $638.0K | $621.0K | $598.0K | $582.0K | $459.0K | $617.0K | $621.0K | $639.0K | $655.0K | $660.0K | $637.0K | $607.0K | $610.0K | $608.0K | |
| Operating Cash Flow | $566M | $-793M | $-138M | $-131M | $151M | $-151M | $-116M | $-115M | $-120M | $-150M | $33M | $-109M | $-97M | $-134M | $-200M | $-24M | |
| CapEx | $16M | $22M | $21M | $5M | $12M | $13M | $25M | $9M | $6M | $4M | $-819.0K | $2M | $12M | $10M | $4M | $6M | |
| Investing Cash Flow | $23M | $537M | $-420M | $91M | $-120M | $170M | $68M | $-341M | $62M | $76M | $-27M | $69M | $70M | $-326M | $212M | $-184M | |
| Stock Issued | · | · | $0 | · | · | · | $27.0K | · | · | · | $0 | · | · | · | · | · | |
| Financing Cash Flow | $-412M | $57M | $591M | $81M | $1M | $2M | $-44M | $496M | $3M | $24M | $41M | $-32M | $144M | $492M | $-51M | $2M | |
| Net Change in Cash | $177M | $-199M | $34M | $41M | $33M | $22M | $-93M | $41M | $-55M | $-50M | $47M | $-73M | $116M | $33M | $-39M | $-207M | |
| Taxes Paid | $1M | $-8.0K | $22.0K | $-278.0K | $17.0K | $-400.0K | $-8M | $80.0K | $2M | $13.0K | · | · | · | · | · | · | |
| Free Cash Flow | · | $-815M | · | · | · | $-163M | · | · | · | $-154M | · | · | · | $-144M | · | · | |
| Levered FCF | · | $-820M | · | · | · | $-167M | · | · | · | $-159M | · | · | · | $-146M | · | · |
Redditività 7
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -38.2% | -47.7% | · | -102.2% | 30.9% | -111.6% | · | -111.1% | -29.3% | -125.1% | · | -99.4% | -47.9% | -87.5% | · | -37.0% | |
| Net Margin | -42.8% | -37.6% | · | -82.1% | 27.3% | -111.6% | · | -105.0% | -29.4% | -119.5% | · | -102.2% | -45.3% | -95.2% | · | -29.4% | |
| Pretax Margin | -42.3% | -37.5% | · | -81.9% | 27.3% | -111.6% | · | -107.7% | -29.4% | -119.4% | · | -97.6% | -41.1% | -86.5% | · | -29.2% | |
| EBITDA Margin | -38.2% | -47.7% | · | -102.2% | 30.9% | -111.6% | · | -111.1% | -29.3% | -125.1% | · | -99.4% | -47.9% | -87.5% | · | -37.0% | |
| ROA | -3.8% | -2.9% | · | -4.2% | 4.3% | -5.3% | · | -4.7% | -2.3% | -5.1% | · | -5.5% | -3.1% | -4.6% | · | -1.9% | |
| ROE | -21.4% | -19.1% | · | -20.1% | 27.6% | -38.0% | · | -28.7% | -19.1% | -36.5% | · | -32.4% | -16.2% | -20.8% | · | -8.3% | |
| ROIC | -23.5% | -23.9% | · | -26.0% | 22.1% | -30.9% | · | -21.9% | -25.1% | -50.4% | · | -47.5% | -23.2% | -25.8% | · | -10.0% |
Liquidità e Solvibilità 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 4.1 | · | 2.8 | 2.9 | 9.7 | · | 8.9 | 7.6 | 7.4 | · | 6.4 | 9.1 | 9.8 | · | 7.6 | |
| Quick Ratio | 6.5 | 2.7 | · | 2.5 | 2.6 | 8.6 | · | 8.2 | 6.8 | 6.7 | · | 5.5 | 8.3 | 9.1 | · | 7.0 | |
| Interest Coverage | -22.2 | -22.8 | · | -38.0 | 34.0 | -35.7 | · | -35.7 | -14.7 | -36.0 | · | -34.1 | -39.4 | -71.0 | · | -27.7 |
Efficienza 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.3 | · | 0.1 | 0.2 | 0.1 | · | 0.0 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Valutazione (TTM) 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $874M | $1.06B | · | $967M | $944M | $717M | · | $803M | $813M | $777M | · | $615M | $631M | $576M | · | $875M | |
| Net Income TTM | $-565M | $-327M | · | $-256M | $-268M | $-458M | · | $-359M | $-366M | $-385M | · | $-409M | $-309M | $-329M | · | $7M | |
| Market Cap | $13.13B | $12.46B | · | $10.54B | $6.29B | $4.80B | · | $6.32B | $6.96B | $6.32B | · | $6.50B | $5.87B | $5.11B | · | $6.28B | |
| P/E | -22.9 | -36.3 | · | -38.7 | -21.5 | -10.1 | · | -16.4 | -18.9 | -16.2 | · | -15.8 | -18.9 | -15.5 | · | -368.6 | |
| P/S | 15.0 | 11.8 | · | 10.9 | 6.7 | 6.7 | · | 7.9 | 8.6 | 8.1 | · | 10.6 | 9.3 | 8.9 | · | 7.2 | |
| P/B | 29.9 | 25.4 | · | 17.1 | 10.0 | 10.1 | · | 9.5 | 26.4 | 21.3 | · | 20.6 | 13.7 | 10.5 | · | 10.6 | |
| P / Tangible Book | 29.9 | 25.4 | · | 17.1 | 10.0 | 10.1 | · | 9.5 | 26.4 | 21.3 | · | 20.6 | 13.7 | 10.5 | · | 11.1 | |
| P / Cash Flow | · | -15.7 | · | · | · | -31.8 | · | · | · | -42.2 | · | · | · | -38.1 | · | · | |
| P / FCF | · | -15.3 | · | · | · | -29.4 | · | · | · | -40.9 | · | · | · | -35.4 | · | · | |
| Earnings Yield | -4.4% | -2.8% | · | -2.6% | -4.7% | -9.9% | · | -6.1% | -5.3% | -6.2% | · | -6.3% | -5.3% | -6.5% | · | -0.27% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utile netto | $-381M | $-454M | $-366M | $-270M | $-29M |
| EPS Diluito | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 3.6 | 2.0 | 3.2 | 2.1 | — |
| Rapporto corrente | 3.8 | 8.5 | 5.9 | 7.1 | 9.7 |
| Quick Ratio | 3.4 | 7.4 | 5.2 | 6.4 | 3.6 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-320M | $-546M | $-331M | $-290M | $19M |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 575 filer · $10.8B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 80 (-4 vs trimestre precedente) | 40 (-25 vs trimestre precedente) | 199 (+17 vs trimestre precedente) | 156 (+3 vs trimestre precedente) | +28.2M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Capital World Investors | $1.718.152.930 | 21.669.226 | 15,90% | Azioni |
| FMR LLC | $1.062.239.646 | 13.396.893 | 9,83% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $623.182.054 | 7.859.529 | 5,77% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $571.799.597 | 7.211.497 | 5,29% | Azioni |
| WELLINGTON MANAGEMENT GROUP LLP | $558.240.214 | 7.040.487 | 5,17% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $495.748.197 | 6.252.342 | 4,59% | Azioni |
| STATE STREET CORP | $343.710.098 | 4.334.848 | 3,18% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $260.920.005 | 3.157.327 | 2,41% | Azioni |
| TWO SIGMA ADVISERS, LP | $241.452.501 | 3.052.111 | 2,23% | Azioni |
| Artisan Partners Limited Partnership | $209.327.536 | 2.640.024 | 1,94% | Azioni |
| Tweedy, Browne Co LLC | $180.805.859 | 2.280.311 | 1,67% | Azioni |
| Deep Track Capital, LP | $174.438.000 | 2.200.000 | 1,61% | Azioni |
| BAKER BROS. ADVISORS LP | $162.364.274 | 2.047.727 | 1,50% | Azioni |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $156.967.955 | 1.979.669 | 1,45% | Azioni |
| AMERICAN CENTURY COMPANIES INC | $154.383.816 | 1.947.076 | 1,43% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $127.260.529 | 1.605.001 | 1,18% | Azioni |
| Pictet Asset Management Holding SA | $126.981.913 | 1.596.998 | 1,18% | Azioni |
| BARCLAYS PLC | $125.150.305 | 1.578.387 | 1,16% | Azioni |
| GOLDMAN SACHS GROUP INC | $117.215.755 | 1.478.317 | 1,08% | Azioni |
| Polar Capital Holdings Plc | $115.289.325 | 1.454.021 | 1,07% | Azioni |
| Alyeska Investment Group, L.P. | $112.426.560 | 1.417.916 | 1,04% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $103.108.716 | 1.300.400 | 0,95% | Opzione Call |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $103.108.000 | 1.300.392 | 0,95% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $84.114.400 | 1.060.845 | 0,78% | Azioni |
| GROUPAMA ASSET MANAGMENT | $75.195.315 | 937.083 | 0,70% | Azioni |
| Capital International Investors | $65.316.248 | 823.764 | 0,60% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $65.184.309 | 822.100 | 0,60% | Opzione Put |
| Davern Capital Partners, LP | $63.329.637 | 798.709 | 0,59% | Azioni |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $62.422.083 | 787.263 | 0,58% | Azioni |
| Connor, Clark & Lunn Investment Management Ltd. | $54.253.072 | 684.236 | 0,50% | Azioni |
| Eversept Partners, LP | $52.702.794 | 664.684 | 0,49% | Azioni |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $51.970.948 | 655.454 | 0,48% | Azioni |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $51.370.722 | 647.884 | 0,48% | Azioni |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $50.113.500 | 632.028 | 0,46% | Azioni |
| Caption Management, LLC | $49.952.700 | 630.000 | 0,46% | Opzione Call |
| NEUBERGER BERMAN GROUP LLC | $46.951.653 | 592.151 | 0,43% | Azioni |
| EVENTIDE ASSET MANAGEMENT, LLC | $45.591.750 | 575.000 | 0,42% | Azioni |
| PERCEPTIVE ADVISORS LLC | $44.878.140 | 566.000 | 0,42% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $44.355.936 | 559.414 | 0,41% | Azioni |
| JANE STREET GROUP, LLC | $44.045.595 | 555.500 | 0,41% | Opzione Call |
| JANE STREET GROUP, LLC | $43.070.328 | 543.200 | 0,40% | Opzione Put |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $41.414.514 | 522.317 | 0,38% | Azioni |
| BOONE CAPITAL MANAGEMENT LLC | $41.228.976 | 519.977 | 0,38% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $39.648.965 | 500.050 | 0,37% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $36.049.119 | 454.649 | 0,33% | Azioni |
| Candriam S.C.A. | $35.251.607 | 445.019 | 0,33% | Azioni |
| FIRST TRUST ADVISORS LP | $33.872.360 | 427.197 | 0,31% | Azioni |
| PINNACLE ASSOCIATES LTD | $33.282.136 | 419.752 | 0,31% | Azioni |
| BANK OF AMERICA CORP /DE/ | $32.643.138 | 411.693 | 0,30% | Azioni |
| NOMURA HOLDINGS INC | $31.889.804 | 402.192 | 0,30% | Azioni |
| Ikarian Capital, LLC | $31.716.000 | 400.000 | 0,29% | Opzione Call |
| CITADEL ADVISORS LLC | $30.645.585 | 386.500 | 0,28% | Opzione Put |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $28.771.090 | 362.859 | 0,27% | Azioni |
| BlackRock, Inc. | $28.184.582 | 355.462 | 0,26% | Azioni |
| Caption Management, LLC | $27.426.411 | 345.900 | 0,25% | Opzione Put |
| TD Asset Management Inc | $27.002.051 | 340.548 | 0,25% | Azioni |
| Freestone Grove Partners LP | $26.955.983 | 339.967 | 0,25% | Azioni |
| AXA Investment Managers S.A. | $26.590.024 | 406.451 | 0,25% | Azioni |
| Qube Research & Technologies Ltd | $26.479.054 | 333.952 | 0,25% | Azioni |
| Capital Research Global Investors | $26.319.205 | 331.936 | 0,24% | Azioni |
| CAPITAL FUND MANAGEMENT S.A. | $26.130.336 | 329.554 | 0,24% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $25.564.391 | 340.450 | 0,24% | Azioni |
| Carmignac Gestion | $25.452.090 | 321.000 | 0,24% | Azioni |
| Privium Fund Management B.V. | $25.366.774 | 319.924 | 0,23% | Azioni |
| Swiss National Bank | $24.976.350 | 315.000 | 0,23% | Azioni |
| ARK Investment Management LLC | $23.848.064 | 300.770 | 0,22% | Azioni |
| Integral Health Asset Management, LLC | $23.787.000 | 300.000 | 0,22% | Opzione Call |
| Ikarian Capital, LLC | $23.787.000 | 300.000 | 0,22% | Opzione Put |
| MILLENNIUM MANAGEMENT LLC | $22.904.661 | 288.872 | 0,21% | Azioni |
| DAVENPORT & Co LLC | $22.515.188 | 283.960 | 0,21% | Azioni |
| Aberdeen Group plc | $21.995.046 | 277.400 | 0,20% | Azioni |
| California Public Employees Retirement System | $21.475.141 | 270.843 | 0,20% | Azioni |
| TimesSquare Capital Management, LLC | $20.700.361 | 275.674 | 0,19% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $20.417.175 | 257.500 | 0,19% | Opzione Call |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $19.918.837 | 251.215 | 0,18% | Azioni |
| CITADEL ADVISORS LLC | $18.709.189 | 235.959 | 0,17% | Azioni |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $18.514.136 | 233.499 | 0,17% | Azioni |
| CITADEL ADVISORS LLC | $18.434.925 | 232.500 | 0,17% | Opzione Call |
| Orion Investment Co | $17.470.362 | 220.335 | 0,16% | Azioni |
| Life Cycle Investment Partners Ltd | $17.435.554 | 219.896 | 0,16% | Azioni |
| ALGERT GLOBAL LLC | $16.401.374 | 206.853 | 0,15% | Azioni |
| Corient Private Wealth LP | $15.603.561 | 196.791 | 0,14% | Azioni |
| Eagle Health Investments LP | $15.428.010 | 194.577 | 0,14% | Azioni |
| SECTOR GAMMA AS | $15.022.918 | 189.468 | 0,14% | Azioni |
| Polymer Capital Management (HK) LTD | $14.105.453 | 177.897 | 0,13% | Azioni |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $13.252.259 | 176.485 | 0,12% | Azioni |
| ADAR1 Capital Management, LLC | $13.184.817 | 166.286 | 0,12% | Azioni |
| RHUMBLINE ADVISERS | $13.075.750 | 164.911 | 0,12% | Azioni |
| Sicart Associates LLC | $12.741.427 | 160.694 | 0,12% | Azioni |
| VANGUARD ASSET MANAGEMENT, Ltd | $12.296.928 | 155.088 | 0,11% | Azioni |
| CSS LLC/IL | $12.074.995 | 152.289 | 0,11% | Azioni |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $11.996.656 | 151.301 | 0,11% | Azioni |
| CITIGROUP INC | $11.996.577 | 151.300 | 0,11% | Opzione Call |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $11.893.500 | 150.000 | 0,11% | Azioni |
| Focus Partners Wealth | $11.728.366 | 147.917 | 0,11% | Azioni |
| Hudson Bay Capital Management LP | $11.497.050 | 145.000 | 0,11% | Azioni |
| Artia Global Partners LP | $11.447.573 | 144.376 | 0,11% | Azioni |
| Sonora Investment Management Group, LLC | $11.108.840 | 169.808 | 0,10% | Azioni |
| Fisher Asset Management, LLC | $10.877.317 | 137.184 | 0,10% | Azioni |
| Atle Fund Management AB | $10.873.116 | 137.131 | 0,10% | Azioni |
Insider aziendali 48 insider · 30 dirigenti · 19 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Brett P Monia | Chief Executive Officer | 26 Giugno 2026 M | 245.571 | 0 | 17 | $-42.648.430 |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 16 Marzo 2026 M | 82.660 | 0 | 6 | $-21.117.075 |
| Kleanthis G Xanthopoulos | President of Regulus | 03 Dicembre 2007 A | — | 0 | 0 | $0 |
| Holly B. Kordasiewicz | EVP, Chief Development Officer | 07 Luglio 2026 S | 22.096 | 0 | 4 | $-4.810.107 |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 07 Luglio 2026 J | 0 | 0 | 14 | $-19.804.154 |
| Eugene Schneider | EVP, Chf Clinical Develop Ofcr | 26 Giugno 2026 M | 77.114 | 0 | 6 | $-4.933.991 |
| Joseph Baroldi | EVP, Chief Business Officer | 26 Giugno 2026 M | 4.669 | 0 | 17 | $-6.405.525 |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 26 Giugno 2026 S | 61.470 | 0 | 16 | $-16.034.086 |
| Eric Swayze | EVP Research | 25 Giugno 2026 S | 21.759 | 0 | 14 | $-8.058.784 |
| Brian Birchler | EVP, Corp and Development Ops | 15 Aprile 2026 M | 67.500 | 0 | 6 | $-3.556.351 |
| Kyle Jenne | EVP, Chf GL Pdt Str Ofcr | 15 Aprile 2026 M | 23.713 | 0 | 4 | $-3.334.240 |
| Shannon L. Devers | EVP, Chief Human Resources Ofc | 02 Aprile 2026 S | 16.348 | 0 | 15 | $-8.854.430 |
| Richard S Geary | EVP, Chief Development Officer | 06 Novembre 2025 M | 59.657 | 0 | 13 | $-13.858.595 |
| Onaiza Cadoret-Manier | EVP,Chf GL Pdt Str & Oper Ofc | 02 Febbraio 2024 S | 35.788 | 0 | 0 | $0 |
| Stanley T Crooke | Exec Chairman of the Board | 26 Gennaio 2021 S | 2.021 | 0 | 0 | $0 |
| Damien Mcdevitt | Chief Business Officer | 15 Luglio 2019 M | 2.573 | 0 | 0 | $0 |
| Sarah Boyce | Chief Business Officer | 15 Gennaio 2018 M | 8.931 | 0 | 0 | $0 |
| ECKER DAVID J | Vice President | 02 Settembre 2008 M | 0 | 0 | 0 | $0 |
| Michael J Treble | Vice President, Pres of Ibis | 11 Agosto 2008 M | 0 | 0 | 0 | $0 |
| Jeffrey M Jonas | Executive Vice President | 02 Gennaio 2008 A | — | 0 | 0 | $0 |
| Mark K Wedel | VP & Chief Medical Officer | 06 Luglio 2007 M | 6.603 | 0 | 0 | $0 |
| LEVIN ARTHUR A | Vice President | 25 Aprile 2007 M | 1.674 | 0 | 0 | $0 |
| BROWN RICHARD K | Vice President | 08 Marzo 2006 M | 2.348 | 0 | 0 | $0 |
| MCNEIL JOHN A | Vice President | 03 Gennaio 2005 A | — | 0 | 0 | $0 |
| LOWENSTAM PATRICIA | Vice President | 03 Gennaio 2005 A | 603 | 0 | 0 | $0 |
| STEIN ARON | Vice President | 01 Luglio 2004 J | 1.536 | 0 | 0 | $0 |
| Hans A De Haan | VP, Drug Development | 27 Aprile 2004 S | 0 | 0 | 0 | $0 |
| LUNDSTEDT KAREN S | Vice President | 10 Marzo 2004 M | 5.407 | 0 | 0 | $0 |
| COLE DOUGLAS L | Vice President | 09 Marzo 2004 M | 9.616 | 0 | 0 | $0 |
| HOLMLUND JON T | Vice President | 01 Luglio 2003 J | 983 | 0 | 0 | $0 |
| Michael R Hayden | Direttore | 31 Luglio 2026 P | 24.000 | 2 | 0 | $1.058.700 |
| Peter N Reikes | Direttore | 15 Luglio 2026 A | 14.222 | 0 | 0 | $0 |
| Ludwig Hantson | Direttore | 15 Luglio 2026 A | — | 0 | 0 | $0 |
| Joan E Herman | Direttore | 15 Luglio 2026 M | 51.306 | 0 | 2 | $-3.173.720 |
| BERTHELSEN SPENCER R | Direttore | 15 Luglio 2026 M | 161.233 | 0 | 2 | $-1.193.280 |
| Allene M. Diaz | Direttore | 07 Luglio 2026 M | 3.811 | 0 | 5 | $-5.278.717 |
| Michael J. Yang | Direttore | 01 Luglio 2026 A | 7.940 | 0 | 0 | $0 |
| Joseph Loscalzo | Direttore | 01 Luglio 2026 A | 36.330 | 0 | 6 | $-8.047.872 |
| Joseph Klein III | Direttore | 01 Luglio 2026 A | 11.014 | 0 | 14 | $-9.356.036 |
| Lynne B Parshall | Direttore | 15 Aprile 2026 S | 51.344 | 0 | 6 | $-2.171.964 |
| Joseph H Wender | Direttore | 01 Dicembre 2025 S | 36.035 | 0 | 13 | $-8.660.283 |
| MUTO FREDERICK T | Direttore | 15 Luglio 2022 M | 59.597 | 0 | 0 | $0 |
| Breaux Castleman | Direttore | 01 Luglio 2020 A | 19.183 | 0 | 0 | $0 |
| REED JOHN C | Direttore | 06 Settembre 2012 M | 0 | 0 | 0 | $0 |
| Richard D Dimarchi | Direttore | 01 Luglio 2010 A | — | 0 | 0 | $0 |
| GARIELI CHRISTOPHER | Direttore | 01 Luglio 2005 A | 155.431 | 0 | 0 | $0 |
| SKALETSKY MARK B | Direttore | 01 Luglio 2004 A | — | 0 | 0 | $0 |
| ISIS PHARMACEUTICALS INC | Proprietario del 10% | 10 Ottobre 2020 P | 98.322.397 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 5 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. (“Ionis”) ×8 depositi | 13 Ottobre 2020 | — | Deposito iniziale | — | SEC |
| Isis Pharmaceuticals, Inc. (“ Isis ”) | 31 Luglio 2015 | — | Deposito iniziale | — | SEC |
| Isis Pharmaceuticals, Inc. (“Isis”), Stanley T. Crooke (“Crooke”), B. Lynne Parshall (“Parshall”) ×2 depositi | 06 Novembre 2014 | — | Deposito iniziale | — | SEC |
| Genzyme Corporation | 15 Gennaio 2008 | — | Deposito iniziale | Investimento passivo | SEC |
| Persona segnalante non divulgata | 12 Aprile 2001 | — | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 85 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 1,74% | 288.230 NS | 30 Aprile 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,72% | 201.598 NS | 30 Aprile 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,48% | 11.708 NS | 30 Aprile 2026 | N-PORT |
| GDOC · Goldman Sachs ETF Trust | 1,37% | 3.614 NS | 31 Maggio 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 1,14% | 414.653 NS | 31 Maggio 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,94% | 64.911 NS | 30 Aprile 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,87% | 150.398 NS | 30 Aprile 2026 | N-PORT |
| TAX · EA Series Trust | 0,87% | 2.885 NS | 29 Maggio 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,84% | 1.257 NS | 30 Aprile 2026 | N-PORT |
| COPY · RBB Fund Trust | 0,84% | 37.653 NS | 31 Maggio 2026 | N-PORT |
| HRTS · Tema ETF Trust | 0,83% | 5.599 NS | 31 Maggio 2026 | N-PORT |
| IBB · iShares Trust | 0,68% | 1.189.984 SH | 08 Agosto 2026 | Giornaliero |
| FFND · Northern Lights Fund Trust II | 0,67% | 9.000 NS | 31 Maggio 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,64% | 8.994 SH | 08 Agosto 2026 | Giornaliero |
| BIB · ProShares Trust | 0,63% | 6.109 NS | 31 Maggio 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 0,58% | 2.153 NS | 30 Aprile 2026 | N-PORT |
| FDMO · FIDELITY COVINGTON TRUST | 0,53% | 60.169 NS | 30 Aprile 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,53% | 36.525 NS | 30 Aprile 2026 | N-PORT |
| OASC · Unified Series Trust | 0,47% | 5.182 NS | 31 Maggio 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,45% | 94.260 SH | 08 Agosto 2026 | Giornaliero |
| CGGR · Capital Group Growth ETF | 0,36% | 1.150.284 NS | 31 Maggio 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,34% | 2.078.639 SH | 08 Agosto 2026 | Giornaliero |
| SMMV · iShares Trust | 0,32% | 17.089 SH | 08 Agosto 2026 | Giornaliero |
| BKMC · BNY Mellon ETF Trust | 0,30% | 25.160 NS | 30 Aprile 2026 | N-PORT |
| ISCG · iShares Trust | 0,28% | 51.765 SH | 08 Agosto 2026 | Giornaliero |
| SCHA · SCHWAB STRATEGIC TRUST | 0,26% | 778.644 NS | 31 Maggio 2026 | N-PORT |
| IWP · iShares Trust | 0,24% | 895.755 SH | 08 Agosto 2026 | Giornaliero |
| SCHM · SCHWAB STRATEGIC TRUST | 0,23% | 438.447 NS | 31 Maggio 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,23% | 71.810 NS | 30 Aprile 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 60.227 NS | 30 Aprile 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,22% | 110.695 SH | 08 Agosto 2026 | Giornaliero |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 62.392 NS | 30 Aprile 2026 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0,21% | 16.403 NS | 30 Aprile 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,20% | 36.263 NS | 30 Aprile 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,20% | 50.927 SH | 08 Agosto 2026 | Giornaliero |
| FHLC · FIDELITY COVINGTON TRUST | 0,19% | 70.978 NS | 30 Aprile 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,18% | 471.609 SH | 08 Agosto 2026 | Giornaliero |
| SMLF · iShares Trust | 0,17% | 133.297 SH | 08 Agosto 2026 | Giornaliero |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,16% | 10.044 NS | 30 Aprile 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,15% | 1.895.610 SH | 08 Agosto 2026 | Giornaliero |
| VB · VANGUARD INDEX FUNDS | 0,15% | 3.600.281 SH | 08 Agosto 2026 | Giornaliero |
| ESML · iShares Trust | 0,15% | 78.764 SH | 08 Agosto 2026 | Giornaliero |
| IYH · iShares Trust | 0,15% | 98.412 SH | 08 Agosto 2026 | Giornaliero |
| NBCR · Neuberger Berman ETF Trust | 0,14% | 16.581 NS | 31 Maggio 2026 | N-PORT |
| ISCB · iShares Trust | 0,14% | 7.328 SH | 08 Agosto 2026 | Giornaliero |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,13% | 176 NS | 31 Maggio 2026 | N-PORT |
| SMMD · iShares Trust | 0,12% | 81.988 SH | 08 Agosto 2026 | Giornaliero |
| WSML · iShares Trust | 0,08% | 9.548 SH | 08 Agosto 2026 | Giornaliero |
| LRND · New York Life Investments ETF Trust | 0,07% | 2.788 NS | 30 Aprile 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,07% | 9.928 SH | 08 Agosto 2026 | Giornaliero |